Metraipolis › archive › dc_c024e7df4f36
Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41578203
- DOI
- 10.1186/s12886-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:00:24.727Z
- SHA-256 of the archived text
ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff- Stable URL of this page
https://metraipolis.com/documento/dc_c024e7df4f36
How to cite
Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203 — Europe PMC (en), https://europepmc.org/article/MED/41578203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c024e7df4f36 (Metraipolis archive dc_c024e7df4f36, sha256 ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff)
BibTeX
@misc{dcc024e7df4f36,
title = {Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41578203},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c024e7df4f36; sha256 ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578203. Agents can read the archived copy with the MCP tool read_document.